252 related articles for article (PubMed ID: 17684335)
1. A human rhinovirus model of chronic obstructive pulmonary disease exacerbations.
Contoli M; Caramori G; Mallia P; Papi A; Johnston SL
Contrib Microbiol; 2007; 14():101-112. PubMed ID: 17684335
[TBL] [Abstract][Full Text] [Related]
2. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
Singanayagam A; Loo SL; Calderazzo M; Finney LJ; Trujillo Torralbo MB; Bakhsoliani E; Girkin J; Veerati P; Pathinayake PS; Nichol KS; Reid A; Footitt J; Wark PAB; Grainge CL; Johnston SL; Bartlett NW; Mallia P
Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L893-L903. PubMed ID: 31513433
[TBL] [Abstract][Full Text] [Related]
3. Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets.
Cafferkey J; Coultas JA; Mallia P
Expert Rev Respir Med; 2020 Aug; 14(8):777-789. PubMed ID: 32498634
[TBL] [Abstract][Full Text] [Related]
4. Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease.
Contoli M; Marku B; Conti V; Saturni S; Caramori G; Papi A
Minerva Med; 2009 Dec; 100(6):467-78. PubMed ID: 20010482
[TBL] [Abstract][Full Text] [Related]
5. Quercetin prevents rhinovirus-induced progression of lung disease in mice with COPD phenotype.
Farazuddin M; Mishra R; Jing Y; Srivastava V; Comstock AT; Sajjan US
PLoS One; 2018; 13(7):e0199612. PubMed ID: 29975735
[TBL] [Abstract][Full Text] [Related]
6. A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD.
Singanayagam A; Glanville N; Walton RP; Aniscenko J; Pearson RM; Pinkerton JW; Horvat JC; Hansbro PM; Bartlett NW; Johnston SL
Clin Sci (Lond); 2015 Aug; 129(3):245-58. PubMed ID: 25783022
[TBL] [Abstract][Full Text] [Related]
7. Experimental rhinovirus infection in COPD: implications for antiviral therapies.
Gunawardana N; Finney L; Johnston SL; Mallia P
Antiviral Res; 2014 Feb; 102():95-105. PubMed ID: 24370732
[TBL] [Abstract][Full Text] [Related]
8. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.
Mallia P; Message SD; Gielen V; Contoli M; Gray K; Kebadze T; Aniscenko J; Laza-Stanca V; Edwards MR; Slater L; Papi A; Stanciu LA; Kon OM; Johnson M; Johnston SL
Am J Respir Crit Care Med; 2011 Mar; 183(6):734-42. PubMed ID: 20889904
[TBL] [Abstract][Full Text] [Related]
9. Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.
Singh M; Lee SH; Porter P; Xu C; Ohno A; Atmar RL; Greenberg SB; Bandi V; Gern J; Amineva S; Aminev A; Skern T; Smithwick P; Perusich S; Barrow N; Roberts L; Corry DB; Kheradmand F
J Allergy Clin Immunol; 2010 Jun; 125(6):1369-1378.e2. PubMed ID: 20430426
[TBL] [Abstract][Full Text] [Related]
10. A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD.
Sasaki T; Nakayama K; Yasuda H; Yamaya M
Ther Adv Respir Dis; 2011 Apr; 5(2):91-103. PubMed ID: 21285157
[TBL] [Abstract][Full Text] [Related]
11. How viral infections cause exacerbation of airway diseases.
Mallia P; Johnston SL
Chest; 2006 Oct; 130(4):1203-10. PubMed ID: 17035457
[TBL] [Abstract][Full Text] [Related]
12. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
[TBL] [Abstract][Full Text] [Related]
13. Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients.
Menzel M; Akbarshahi H; Bjermer L; Uller L
Sci Rep; 2016 Jun; 6():28698. PubMed ID: 27350308
[TBL] [Abstract][Full Text] [Related]
14. An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study.
Mallia P; Message SD; Kebadze T; Parker HL; Kon OM; Johnston SL
Respir Res; 2006 Sep; 7(1):116. PubMed ID: 16956406
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of Viral Infection in Exacerbations of Airway Disease.
Ritchie AI; Farne HA; Singanayagam A; Jackson DJ; Mallia P; Johnston SL
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S115-32. PubMed ID: 26595727
[TBL] [Abstract][Full Text] [Related]
16. Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.
Del Vecchio AM; Branigan PJ; Barnathan ES; Flavin SK; Silkoff PE; Turner RB
Pulm Pharmacol Ther; 2015 Feb; 30():32-43. PubMed ID: 25445932
[TBL] [Abstract][Full Text] [Related]
17. Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations.
Mallia P; Contoli M; Caramori G; Pandit A; Johnston SL; Papi A
Curr Pharm Des; 2007; 13(1):73-97. PubMed ID: 17266589
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Chronic Obstructive Pulmonary Disease Exacerbations.
Wedzicha JA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S157-9. PubMed ID: 26595732
[TBL] [Abstract][Full Text] [Related]
19. Models of infection and exacerbations in COPD.
Papi A; Contoli M; Caramori G; Mallia P; Johnston SL
Curr Opin Pharmacol; 2007 Jun; 7(3):259-65. PubMed ID: 17475555
[TBL] [Abstract][Full Text] [Related]
20. Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.
Footitt J; Mallia P; Durham AL; Ho WE; Trujillo-Torralbo MB; Telcian AG; Del Rosario A; Chang C; Peh HY; Kebadze T; Aniscenko J; Stanciu L; Essilfie-Quaye S; Ito K; Barnes PJ; Elkin SL; Kon OM; Wong WS; Adcock IM; Johnston SL
Chest; 2016 Jan; 149(1):62-73. PubMed ID: 25790167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
